By Togas Tulandi
Analyzes a variety of reproductive and gynecological issues encountered within the care of ladies who don't desire to conceive, in addition to those that have trouble with belief, early being pregnant, and menopause. Discusses the most recent innovations within the remedy of infertility, pelvic soreness, ectopic being pregnant, and osteoporosis.
Read or Download Reproductive Endocrinology and Infertility: Current Trends and Developments PDF
Best endocrinology books
Uncomplicated scientific Endocrinology, 3rd variation offers updated insurance of quickly unfolding advances within the knowing of hormones fascinated with regulating such a lot elements of physically features. The dialogue specializes in molecular and mobile points of hormone creation and motion firmly rooted within the context of integrative body structure.
Until eventually lately, the renin-angiotensin-aldosterone approach has been thought of a systemic endocrine hormonal method completely. it truly is referred to now that every element of the renin-angiotensin process is produced, synthesized and certainly, found in many organisms together with the guts and vessels. This quantity provides the newest medical and laboratory reports of the prime physicians and investigators within the box of the neighborhood cardiac renin-angiotensin aldosterone procedure.
Magnesium is the fourth so much considerable mineral within the physique and is vital to solid health and wellbeing. nearly 50 in keeping with cent of overall physique magnesium is located in bone. the opposite part is located predominantly within cells of physique tissues and organs. only one in line with cent of magnesium is located in blood, however the physique works very tough to maintain blood degrees of magnesium consistent.
- Klinische Endokrinologie für Frauenärzte
- Abnormalities in puberty : scientific and clinical advances
- Endocrinology of Embryo-Endometrium Interactions
Additional info for Reproductive Endocrinology and Infertility: Current Trends and Developments
Am J Obstet Gynecol 1999; 181:539–544. Kaunitz A. Efﬁcacy cycle control and safety of two triphasic oral contraceptives cyllessa (Desogestrel/ethinyl estradiol) and Ortho-Novum 7/7/7 (norethindrone/ethynylestradiol). Contraception 2000; 61:295– 302. Sullivan H, Furniss H, Spona J, Eisteer M. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 µg) and ethinyl estradiol (15 µg) on ovarian activity. Fertil Steril 1999; 72:115–120. Copyright 2003 by Marcel Dekker, Inc.
However, one could theorize that with even less estrogen, there may be a role for these OCs during this period. VI. CONCLUSIONS With the current dilemma for healthcare providers of select populations and the decision about whether or not to prescribe OCs, perhaps ultralow-dose pills can ﬁll the void and allow OCs to reach larger patient populations. Speciﬁcally, ultra-low dose pills may be especially effective in smokers over 35 years old; individuals with hypertension, diabetes mellitus, migraine headaches, uterine leiomyomata, or lipid disor- Copyright 2003 by Marcel Dekker, Inc.
The decline in the production of ovarian and adrenal androgens that commences in the decade preceding menopause may have an impact on women’s health. The clinical sequelae of androgen deﬁciency in menopausal women have only recently been acknowledged, and androgen replacement for those who are symptomatic is becoming an increasingly important therapeutic option. It has been known that androgen (A) when added to estrogen (E) improves libido since 1950 [1,2]. The information then was anecdotal, and it was not until the mid-1980s that Sherwin and Gelfand demonstrated that the addition of androgen to estrogen in hormone replacement therapy (HRT) improved sexuality, energy, and well-being as well as augmenting libido [3–6].